|

Neoadjuvant cadonilimab combined with perioperative SOX Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Zuoyi Jiao1

Indications

  • ORR,OS,PFS1
  • MPR1
  • pCR Rate1
  • Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])1
  • Adjuvant Chemotherapy1

Other1 trial

Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.